Annual Report

The report describes 16% growth in Biocon Group revenues for FY2012, driven by research services and branded formulations. It reports combined Syngene and Clinigene research-services sales of ` 4,101 million, with year-on-year growth of over 29%. The company also reports implementing environmental and occupational health and safety management systems certified at its manufacturing sites.